UNSPSC 51141546: Ameltolide

This classification denotes an anticonvulsant agent with the molecular formula C15H16N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F83240ZOVE, chemically known as 4-amino-n-(2,6-dimethylphenyl)benzamide but generally known as ameltolide, which bears US NIH Compound Identifier 13086. European Medicines Agency schedules Ameltolide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05408MIG.

UNSPSC 51141546 Ameltolide is a Commodity code that appears to capture pharmaceutical and medical supply procurement, though the recent state and local activity tagged to this code shows a significant scope mismatch. Seminole County, Florida issued an IFB in June 2026 for naloxone and drug deactivation systems — opioid-reversal medication and harm-reduction equipment — rather than ameltolide specifically. State and local governments use procurement codes at the commodity level to tag highly specific products, and the one recent opportunity under this code does not align with the code's nominal pharmaceutical agent classification. The solicitation required quarterly delivery of 1,900 units of naloxone and 800 safe drug deactivation systems annually to the Seminole County Community Health Building, with vendors responsible for all shipping and delivery costs, electronic bid submission through the county's e-Procurement Portal, and compliance with drug-free workplace and E-Verify requirements.

The geographic signal from this code is limited to Florida based on the single recent posting. Seminole County's IFB (number IFB60459723LAS, due July 26, 2023) represents a health department or community health purchasing initiative rather than a broad state-level procurement pattern. The contract carried a two-year initial term with an optional one-year renewal, included a three-month probationary termination clause, and was potentially funded through FEMA, triggering federal compliance overlays such as Clean Air Act and Federal Water Pollution Control Act adherence. No explicit set-aside designations were specified. The code shows minimal recent state and local activity, and the single opportunity present is not a reliable indicator of broader ameltolide procurement demand across jurisdictions. Business development professionals should treat this code as dormant at the state and local level pending additional opportunities.